Magenta Therapeutics Inc logo

Magenta Therapeutics Inc

$ 1.58 +0.031 (+2%) 03:23 PM EST
P/E:
At Loss
P/B:
0.83
Market Cap:
$ 102.90M
Enterprise V:
$ -16.54M
Volume:
604.91K
Avg Vol (2M):
242.02K
Volume:
604.91K
Market Cap $:
102.90M
PE Ratio:
At Loss
Avg Vol (2-Month):
242.02K
Enterprise Value $:
-16.54M
PB Ratio:
0.83
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Magenta Therapeutics Inc
NAICS : 325412 SIC : 2834
100 Technology Square, 5th Floor, Cambridge, MA, USA, 02139
Description
Magenta Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing novel medicines to extend the curative power of stem cell transplant, gene therapy, genome editing, and cell therapy. The pipeline of the company includes MGTA-117, MGTA-145, and others.
Name Current Vs Industry Vs History
Cash-To-Debt 4.41
Equity-to-Asset 0.78
Debt-to-Equity 0.23
Debt-to-EBITDA -0.41
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 31.79
9-Day RSI 39.28
14-Day RSI 44.02
6-1 Month Momentum % -34.55
12-1 Month Momentum % -68.02

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12.62
Quick Ratio 12.62
Cash Ratio 12.39

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -20.9
Name Current Vs Industry Vs History
ROE % -45.15
ROA % -39.01
ROIC % -383.29
ROC (Joel Greenblatt) % -458.77
ROCE % -43.24

Financials (Next Earnings Date:2022-11-04 Est.)

MGTA's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:MGTA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -1.31
Beta 1.91
Volatility % 72.33
14-Day RSI 44.02
14-Day ATR ($) 0.172749
20-Day SMA ($) 1.69575
12-1 Month Momentum % -68.02
52-Week Range ($) 0.9231 - 8.49
Shares Outstanding (Mil) 58.89

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Magenta Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More